Bayer(BAYRY)
$14.65-0.36 (-2.40%)
BAYRY
Bayer stock drug pipeline
$14.65
At close:-0.36 (-2.40%)
Want to see BAYRY full AI Analyst Report?
Bayer (BAYRY) Drug Pipeline
2,118 Followers
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Bayer AG (BAYRY) have in its pipeline
Bayer BAYRY is currently developing the following drugs: Pembrolizumab, Vvd-133214, Metformin, Sevabertinib, Nurandociguat Old Tablet - Sd, Nurandociguat New Tablet - Sd, Nurandociguat Old Tablet, Nurandociguat New Tablet, Elinzanetant Treatment A, Elinzanetant Treatment B, Docetaxel, Enzalutamide, Darolutamide, Rinzimetostat, Taxotere, Oric-944, Aspirin, Bay3389934, Bay 3670549, Oxymetazoline Hcl 0.05% Nasal Gel, Ab-1005, Cetuximab, Bay 3771249, Nitroglycerin Spray, Nurandociguat, Darolutamide, Adt, Acoramidis, Ab-1009, Darolutamide, Valemetostat, Treatment A, Treatment B, Treatment C, Prescriptive Infusion Algorithm, Ab-1005, Bay 3401016, Finerenone, Bay 3389934, Finerenone: Intervention A, Finerenone: Intervention B, Sevabertinib, Bay3723113, Sham Surgery, Bemdaneprocel, Bay 3713372, Bay865028, Medroxyprogesterone Acetate, Bay3389934, Opct-001, Bay2927088, Bay 3547926, Bay 3547922, Acetylsalicylic Acid, Bay3498264, Bay3018250 Dose 1, Bay3018250 Dose 2, Bay3018250 Dose 1, Bay3018250 Dose 2 Infusion, Bay3018250 Dose 2 Injection, Bay3283142, Pembrolizumab, Pemetrexed, Carboplatin, Cisplatin, Bay2927088, Bay3630942, Bay3547922. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

